S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Compassus Marks Two Decades of Growth in Home-Based Care

Founded in 2006 to transform care for those facing serious illness, Brentwood-based Compassus is now celebrating its 20th anniversary. The provider has evolved from a singular vision into a national network serving 180,000 patients annually across 33 states, backed by a workforce of 10,000 employees.

Compassus Marks Two Decades of Growth in Home-Based Care
Photo: Bio & News

The organization’s trajectory reflects a broader shift in the healthcare landscape, moving services away from hospitals and into the domestic setting. Since 2020, Compassus has aggressively scaled its collaborative model, forging strategic partnerships with major health systems including Ascension, Bon Secours Mercy Health, OhioHealth, and Providence. These alliances allow the company to share clinical and administrative resources while maintaining a focus on person-centered palliative, hospice, and home health services.

CEO Mike Asselta credits this expansion to the company’s ability to integrate scale with specialized care delivery. Beyond its footprint, the firm has secured recognition from industry observers, including placement on the Nashville Business Journal’s fastest-growing companies list and various SHPBest™ Top Performer awards. As the provider enters its third decade, leadership plans to double down on clinical innovation and collaborative models to meet the rising demand for care among the nation's aging population.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!